Pieces of the plan are in place, but we must continue to strengthen preparedness research capacity
Infectious diseases continue to threaten global health security,1 despite decades of advances in hygiene, vaccination and antimicrobial therapies. Population growth, widespread international travel and trade, political instability and climate change have caused rapid changes in human populations, wildlife and agriculture, in turn increasing the risk of infection transmission within and between countries and from animal species.2 New human pathogens have emerged, and previously “controlled” diseases have re-emerged or expanded their range.2 In the past decade alone, the global community has experienced infection outbreaks of pandemic influenza, Ebola and Zika viruses and Middle East respiratory syndrome (MERS).
- 1. McCloskey B, Dar O, Zumla A, Heymann DL. Emerging infectious diseases and pandemic potential: status quo and reducing risk of global spread. Lancet Infect Dis 2014; 14: 1001-1010.
- 2. Heesterbeek H, Anderson RM, Andreasen V, et al. Modeling infectious disease dynamics in the complex landscape of global health. Science 2015; 347: aaa4339.
- 3. Bishop JF, Murnane MP, Owen R. Australia’s winter with the 2009 pandemic influenza A (H1N1) virus. N Engl J Med 2009; 361: 2591-2594.
- 4. Australian Government. Review of Australia’s health sector response to pandemic (H1N1) 2009: lessons identified. Canberra: Department of Health and Ageing, 2011. https://www.health.gov.au/internet/publications/publishing.nsf/Content/review-2011-l/$File/lessons%20identified-oct11.pdf (accessed Feb 2017).
- 5. Use of neuraminidase inhibitors in influenza. London: Academy of Medical Sciences and Wellcome Trust, 2015. https://acmedsci.ac.uk/file-download/38069-561595082cd83.pdf (accessed Feb 2017).
- 6. McVernon J, Laurie K, Faddy H, et al. Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia. Influenza Other Respir Viruses 2014; 8: 194-200.
- 7. Greco D, Stern EK, Marks G. Review of ECDC’s response to the influenza pandemic 2009–2010. Stockholm: European Centre for Disease Prevention and Control, 2011. http://ecdc.europa.eu/en/aboutus/Key%20Documents/241111COR_Pandemic_response.pdf (accessed Feb 2017).
- 8. Australian Government. Australian health management plan for pandemic influenza. Canberra: Department of Health, 2014. https://www.health.gov.au/internet/main/publishing.nsf/Content/519F9392797E2DDCCA257D47001B9948/$File/AHMPPI.pdf (accessed Feb 2017).
- 9. Firman J, Williams SA, Baggoley C. From plague to MERS: coordinating Australia’s response to emerging infectious diseases. Public Health Res Pract 2016; 26: e2651654. doi: http://dx.doi.org/10.17061/phrp2651654.
- 10. Communicable Diseases Network Australia, Australian Health Protection Principal Committee. CDPLAN: Emergency response plan for communicable disease incidents of national significance. Canberra: Department of Health, 2016. https://www.health.gov.au/internet/main/publishing.nsf/Content/7A38C92C483C8B77CA25805E001A402D/$File/CDPLAN.pdf (accessed Feb 2017).
- 11. Australian Government. National framework for communicable disease control. Canberra: Department of Health, 2014. http://www.health.gov.au/internet/main/publishing.nsf/Content/ohp-nat-frame-communic-disease-control.htm (accessed Feb 2017).
- 12. World Health Organization. An R&D blueprint for action to prevent epidemics: plan of action May 2016. Geneva: WHO, 2016. http://www.who.int/csr/research-and-development/WHO-R_D-Final10.pdf (accessed Feb 2017).
- 13. Kieny MP, Rottingen JA, Farrar J; on behalf of the WHO R&D Blueprint team the R&D Blueprint Scientific Advisory Group. The need for global R&D coordination for infectious diseases with epidemic potential. Lancet 2016; 388: 460-461.
- 14. National Health and Medical Research Council. Infectious disease emergency response research funding [media release]. 1 July 2016. https://www.nhmrc.gov.au/media/releases/2016/infectious-disease-emergency-response-research-funding (accessed Jan 2017).
- 15. Delfraissy JF, Yazdanpanah Y, Levy Y. REACTing: the French response to infectious disease crises. Lancet 2016; 387: 2183-2185.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.